Floatz logo

Anti-Thymoglobulin, Rabbit

Myelodysplastic Syndrome (MDS)

Peking University First HospitalPhase 2/3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

314 Active assets in the Myelodysplastic Syndrome (MDS) cohort.

Asset / SponsorPhaseRating
FILGRASTIM
City of Hope Medical Center
Phase 4BB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
Fludarabine
Sawa Ito, MD
Phase 4BB
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB
Cyclophosphamide
Sawa Ito, MD
Phase 4BB

View all 50 →

Same molecule, other indications

Anti-Thymoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
72 / 100
View asset →
myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →